CoStar Group, Inc.
CoStar Group, Inc. (CSGP) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for CoStar Group, Inc. (CSGP), covering cash flow, earnings, and balance sheets.
CoStar Group, Inc. (CSGP) Income Statement & Financial Overview
Review CoStar Group, Inc. CSGP income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $732.20M | $709.40M | $692.60M | $677.80M |
| Cost of Revenue | $153.30M | $140.90M | $140.60M | $151.30M |
| Gross Profit | $578.90M | $568.50M | $552.00M | $526.50M |
| Gross Profit Ratio | $0.79 | $0.80 | $0.80 | $0.78 |
| R&D Expenses | $94.50M | $82.30M | $81.00M | $79.60M |
| SG&A Expenses | $510.00M | $433.40M | $437.00M | $468.30M |
| Operating Expenses | $621.70M | $528.50M | $518.00M | $547.90M |
| Total Costs & Expenses | $775.00M | $669.40M | $674.30M | $699.20M |
| Interest Income | $0.00 | $53.60M | $55.60M | $53.50M |
| Interest Expense | $0.00 | $6.40M | $0.00 | $0.00 |
| Depreciation & Amortization | $47.30M | $39.30M | $35.50M | $38.80M |
| EBITDA | $4.50M | $79.30M | $59.20M | $22.70M |
| EBITDA Ratio | $0.006 | $0.11 | $0.09 | $0.03 |
| Operating Income | -$42.80M | $40.00M | $23.70M | -$21.40M |
| Operating Income Ratio | -$0.06 | $0.06 | $0.03 | -$0.03 |
| Other Income/Expenses (Net) | $36.10M | $45.00M | $54.00M | $52.00M |
| Income Before Tax | -$6.70M | $85.00M | $77.70M | $35.90M |
| Income Before Tax Ratio | -$0.009 | $0.12 | $0.11 | $0.05 |
| Income Tax Expense | $8.10M | $25.20M | $24.70M | $16.70M |
| Net Income | -$14.80M | $59.80M | $53.00M | $19.20M |
| Net Income Ratio | -$0.02 | $0.08 | $0.08 | $0.03 |
| EPS | -$0.04 | $0.15 | $0.13 | $0.05 |
| Diluted EPS | -$0.04 | $0.15 | $0.13 | $0.05 |
| Weighted Avg Shares Outstanding | $410.50M | $406.90M | $406.80M | $406.00M |
| Weighted Avg Shares Outstanding (Diluted) | $410.50M | $408.40M | $408.00M | $407.40M |
The company's financials show resilient growth, with revenue advancing from $677.80M in Q2 2024 to $732.20M in Q1 2025. Gross profit remained healthy with margins at 79% in Q1 2025 compared to 78% in Q2 2024. Operating income hit -$42.80M last quarter, sustaining a consistent -6% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $4.50M. Net income dropped to -$14.80M, while earnings per share reached -$0.04. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan